Stock search

Ticker or company name

WST card

WST price forecast

West Pharmaceutical Services$417,80

P/E now is 46,9. Average over 5 years: 42,2 (range 35–47). The stock is 11% above its history.

Base · FY2030

$515,91+5,5% a year

The base case gives 5,5% a year, below your target of 10%.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2026FY2027FY2028FY2029FY2030
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$3,30 bn$3,55 bn$3,81 bn$4,10 bn$4,40 bn
Net income$640 m$688 m$739 m$794 m$853 m
EPS$8,88$9,62$10,42$11,29$12,23

Changed values are highlighted. Bear and bull cases: growth ∓ 13,6%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $417,80

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2030

Bear$195,74

Price change
−53,1%
A year
−16,5%
Fair value today
$134,32
Margin of safety
−67,8%

Base$515,91

Price change
+23,5%
A year
+5,5%
Fair value today
$352,20
Margin of safety
−15,7%

Bull$1 156,76

Price change
+176,9%
A year
+28,3%
Fair value today
$787,61
Margin of safety
+88,5%

What growth the price implies

For the stock to return 10% a year, revenue must grow 11,4% a year to FY2030 at a 19,4% margin and P/E 42,2.

Growth over 5 years
7,4%
Analyst consensus
no data
In your model
7,4%

Calculated from your assumptions. Not an investment recommendation.

Base · FY2030$515,91+5,5% a year